Life Made Easy in Allergic Rhinitis
D E S C R I P T I O N / M O D E O F A C T I O N
RemCC- LM is a unique combination useful in treatment of Allergic Rhinitis.
Levocetirizine is a second generation antihistamine that is effective in reducing sneezing and runny nose and is a mainstay therapy for allergic rhinitis. Montelukast helps in reducing symptoms of allergic rhinitis that are not controlled with antihistamines alone by competitively and reversibly inhibits cysteinyl leukotrienes (CysLTs), specifically leukotrienes D4 (LTD4), theoretically decreasing congestion and stuffiness associated with allergic rhinitis and in comparison to antihistamines appear to have significantly better improvement in night time symptoms
C O M P O S I T I O N
|
I N D I C AT I O N S
|
D O S A G E
Tablets:
Adults : 1 tablet once daily (at evening)
Syrup : Children (6 – 14 years): 1 tsp once daily (at evening)
Children (2 – 6years) : ½ tsp once daily (at evening)
S I D E E F F E C T S
Most common adverse reactions (incidence ≥5%) reported with Montelukast are upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhea, otitis media, influenza, rhinorrhea, sinusitis, otitis.
The most common adverse reactions reported with Levocetirizine (rate ≥2%) were somnolence, nasopharyngitis, fatigue, dry mouth, and pharyngitis in subjects 12 years of age and older, pyrexia, somnolence, cough, and epistaxis in children 6 to 12 years of age and pyrexia, diarrhea, vomiting, and otitis media in subjects 1 to 5 years of age. In children 6 to 11 months of age, the most common adverse reactions (rate ≥3%) were diarrhea and constipation.
P R E S E N TAT I O N & PACK
Syrup : Bottle of 30 ml with measuring cap in a carton.
Tablets : Box of 10×10’s tablets in blister strips.
